Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a
- PMID: 11396377
Clinical pregnancy rates in an IVF program. Use of the flare-up protocol after failure with long regimens of GnRH-a
Abstract
Objective: To examine the efficacy of flare-up protocols in patients who failed to respond to a long protocol using gonadotropin-releasing hormone agonist (GnRH-a).
Study design: In this retrospective study, a total of 144 patients who underwent an in vitro fertilization/embryo transfer cycle with the flare-up protocol were analyzed. Of these, 111 patients (group I) had not responded well to ovulation induction with long-term down-regulation with GnRH-a (long protocol), and 33 (group II) had responded to ovulation induction with at least four follicles but failed to conceive after embryo transfer. The average age of the patients were 37.3 +/- 3.9 years (range, 28-43) and 36.5 +/- 3.7 (range, 24-44), respectively. All patients underwent a flare-up protocol with GnRH-a (leuprolide acetate, 0.5 mg/d) on day 2 and at least 6 ampules of gonadotropins on day 3 within 6 months following failure with the long protocol. Unresponsiveness was defined as having fewer than three developing follicles on day 7, with an estradiol level < 200 pg/mL. Patients with a cycle day 2 follicle stimulating hormone (FSH) level > 15 mIU/mL before initiating GnRH-a were not included in the flare-up protocol. The average day 2 FSH levels of the patients on the flare-up protocol cycles were 9.1 +/- 3.0 in group I and 7.1 +/- 2.0 in group II.
Results: In group I, 44 of 111 (39.6%) patients did not respond to the flare-up protocol even with an increased dose of gonadotropins. In 67 patients, an average of 7.2 +/- 2.3 oocytes were obtained. Embryo transfer was performed on 64 patients with an average of 3.2 +/- 0.6 embryos. Fertilization did not occur in three patients. Eleven women conceived, eight of them miscarried, and three delivered. The pregnancy rate per cycle initiated was 9.9% (11/111) and live birth rate per cycle initiated, 2.5% (3/111). In group II, 3 of 33 patients were cancelled. The reasons were inadequate ovarian response, risk of hyperstimulation and absence of oocytes after aspiration. In 28 patients the average number of oocytes obtained was 6.9 +/- 3.9, and the average number of embryos replaced was 2.7 +/- 1.0. Six patients conceived, and all miscarried. The pregnancy rate per cycle initiated was 6/33 (18.1%), and no live births were achieved.
Conclusion: Although the flare-up protocol after an unsuccessful luteal phase long protocol increases the pregnancy rate per cycle slightly, the live birth rate is not improved in poor responders.
Similar articles
-
A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.Fertil Steril. 2010 Feb;93(2):360-3. doi: 10.1016/j.fertnstert.2008.11.007. Epub 2009 Jan 7. Fertil Steril. 2010. PMID: 19131055
-
Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.Fertil Steril. 2009 Jun;91(6):2437-44. doi: 10.1016/j.fertnstert.2008.03.057. Epub 2008 Jun 13. Fertil Steril. 2009. PMID: 18555238 Clinical Trial.
-
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.J Clin Endocrinol Metab. 2003 Jan;88(1):166-73. doi: 10.1210/jc.2002-020788. J Clin Endocrinol Metab. 2003. PMID: 12519847 Clinical Trial.
-
Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.Reprod Sci. 2021 Feb;28(2):495-509. doi: 10.1007/s43032-020-00307-2. Epub 2020 Sep 4. Reprod Sci. 2021. PMID: 32886340 Review.
-
In vitro fertilisation. A review of drug therapy and clinical management.Drugs. 1996 Sep;52(3):313-43. doi: 10.2165/00003495-199652030-00002. Drugs. 1996. PMID: 8875126 Review.
Cited by
-
Modified natural cycle using GnRH antagonist can be an optional treatment in poor responders undergoing IVF.J Assist Reprod Genet. 2005 Feb;22(2):75-9. doi: 10.1007/s10815-005-1496-2. J Assist Reprod Genet. 2005. PMID: 15844732 Free PMC article. Clinical Trial.
-
Treatment-associated serum FSH levels in very poor responders to ovarian stimulation.J Assist Reprod Genet. 2003 Oct;20(10):395-9. doi: 10.1023/a:1026280508821. J Assist Reprod Genet. 2003. PMID: 14649378 Free PMC article.